Key facts
- It has raised $1.5M; the latest was Seed Round ($1.1M) in Jun 2025.
- Notable investors include Imec.istart, Astylab Ventures, Evercurious VC, Hellenic Business Angels Network, Lumiares — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Koios
- ·The full record, as it builds
Funding rounds
No funding rounds for Koios are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Koios
Developer of a digital platform designed to improve care and decrease costs that will pave the way for improved quality care for people with neuro and chronic diseases. The company's platform offers early-stage and disease progression screening, medication effectiveness quantification, and round-the-clock passive monitoring of physical activity, sleep quality, social behavior, drug adherence, and meal intake for personalized insights, enabling healthcare systems and individuals to advance the quality and efficiency of care.
- Sector
- Healthcare
- HQ
- Antwerp, Belgium
- Founded
- 2022
- Employees
- 7
- Website
- koios.care/
- Ownership
- Privately Held (backing)
Koios doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Koios shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Koios in its N-PORT filings yet. We sweep new filings monthly.